Background: Chemerin is a newly discovered adipokine, which has been reported to be
associated with the presence of dilated cardiomyopathy (DCM). The present study aims to …

Background Recent evidence demonstrated that the circulating concentrations of adipokine
are related to the presence of heart failure secondary to ischemic heart disease and dilated …

Background It has been documented that circulating chemerin is associated with
inflammation, metabolic syndrome, and coronary artery disease. The present study was …

Background Adipokine chemerin was proven to be associated with coronary artery disease
(CAD), but its prognostic implications in CAD remain unclear. Methods This study consists of …

Objectives: The newly identified adipokine chemerin has been shown to be associated with
the components of MetS, inflammation and insulin resistance. In this study, the relationship …

Background: Left ventricular hypertrophy (LVH) is an important predictor of cardiovascular
risk and its detection contributes to risk stratification. Chemerin is a secreted protein with a …

Objectives To evaluate chemerin levels in patients with coronary artery disease and detect
the correlation between these levels (if any) with the severity of coronary artery disease …

Objective Chemerin, a newly discovered adipokine, is correlated with hypertension,
diabetes and coronary heart disease. The aim of this study is to investigate the association …

Background Chemerin is a novel adipokine that is associated with inflammation and
adipogenesis. However, it remains unclear whether chemerin is involved in patients with …

Objective Patients with metabolic syndrome (MetS) are at a high risk for developing
atherosclerosis and cardiovascular disease. Serum levels of chemerin have been found …